Bioatla logo

Bioatla Share Price (NASDAQ: BCAB)

$0.45

0.03

(7.14%)

Last updated on

Check the interactive Bioatla Stock chart to analyse performance

Bioatla stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$0.43
    Today's High:$0.45

    Day's Volatility :5.38%

  • 52 Weeks Low:$0.24
    52 Weeks High:$2.53

    52 Weeks Volatility :90.5%

Bioatla Stock Returns

PeriodBioatla IncSector (Health Care)Index (Russel 2000)
3 Months
-11.06%
3.6%
0.0%
6 Months
48.77%
-7.7%
0.0%
1 Year
-75.21%
-12.6%
0.0%
3 Years
-94.6%
9.5%
-4.7%

Bioatla Inc Key Stats

Check Bioatla key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.42
Open
$0.437
Today's High
$0.4536
Today's Low
$0.4292
Market Capitalization
$24.7M
Today's Volume
$681.8K
52 Week High
$2.525
52 Week Low
$0.24
Revenue TTM
$11.0M
EBITDA
$-62.5M
Earnings Per Share (EPS)
$-1.1
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-813.88%

Stock Returns calculator for Bioatla Stock including INR - Dollar returns

The Bioatla stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bioatla investment value today

Current value as on today

₹30,708

Returns

₹69,292

(-69.29%)

Returns from Bioatla Stock

₹74,576 (-74.58%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Bioatla Stock

217%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Bioatla Stock from India on INDmoney has increased by 217% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Bioatla Inc

  • Name

    Holdings %

  • Vanguard Group Inc

    3.04%

  • Acadian Asset Management LLC

    2.88%

  • TANG CAPITAL MANAGEMENT LLC

    2.34%

  • Renaissance Technologies Corp

    1.27%

  • Morgan Stanley - Brokerage Accounts

    1.01%

  • BlackRock Inc

    1.01%

Analyst Recommendation on Bioatla Stock

Rating
Trend

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Bioatla(by analysts ranked 0 to 5 stars)

Bioatla Share Price Target

What analysts predicted

Upside of 2122.22%

Target:

$10.00

Current:

$0.45

Bioatla share price target is $10.00, a slight Upside of 2122.22% compared to current price of $0.45 as per analysts' prediction.

Bioatla Stock Insights

  • Price Movement

    In the last 7 days, BCAB stock has moved up by 27.3%
  • BCAB vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 144.3%
  • BCAB vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 207.1%
  • Price to Sales

    ForBCAB every $1 of sales, investors are willing to pay $2.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Bioatla Technicals Summary

Sell

Neutral

Buy

Bioatla is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Bioatla Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Bioatla Inc logo
37.45%
48.77%
-75.21%
-94.6%
-98.54%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Bioatla Inc

BioAtla, Inc., a clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. The company's lead clinical stage product candidates include mecbotamab vedotin (BA3011), a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for treating undifferentiated pleomorphic sarcoma and non-small cell lung cancer (NSCLC); and ozuriftabmab vedotin (BA3021), a CAB ADC to treat melanoma and squamous cell carcinoma of head and neck. It is also developing Evalstotug (BA3071), a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for treating melanoma, renal cell carcinoma, colorectal cancer, and NSCLC; BA3182, a bispecific candidate to treat adenocarcinomas; BA3361, a CAB-Nectin-4-ADC for treating tumors; BA3142, a dual-CAB T-cell engager targeting B7-H3, a protein expressed on various solid tumors; and preclinical candidate for CAB-Nectin 4 x CAB-CD3. The company was founded in 2007 and is headquartered in San Diego, California.
Organization
Bioatla
Employees
61
CEO
Dr. Jay M. Short Ph.D.
Industry
Healthcare

Key Management of Bioatla Inc

NameTitle
Dr. Jay M. Short Ph.D.
Co-Founder, CEO & Chairman
Mr. Richard A. Waldron
Senior VP & CFO
Dr. Eric L. Sievers M.D.
Chief Medical Officer
Ms. Susie Melody
Senior Vice President of Human Resources
Dr. Cathy Chang Ph.D.
Senior Vice President of Research & Development
Dr. Gerhard Frey Ph.D.
Senior Vice President of Technology Development
Ms. Monica Sullivan
Senior Vice President of Intellectual Property & Contracts
Ms. Sheri Lydick
Chief Commercial Officer
Lisa M. Pelton
Accounting Manager

Important FAQs about investing in BCAB Stock from India :

What is Bioatla share price today?

Bioatla share price today is $0.45 as on at the close of the market. Bioatla share today touched a day high of $0.45 and a low of $0.43.

What is the 52 week high and 52 week low for Bioatla share?

Bioatla share touched a 52 week high of $2.53 and a 52 week low of $0.24. Bioatla stock price today i.e. is closed at $0.45, lower by 82.18% versus the 52 week high.

How to invest in Bioatla Stock (BCAB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bioatla on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bioatla Shares that will get you 3.3333 shares as per Bioatla share price of $0.45 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Bioatla Stock (BCAB) from India?

Indian investors can start investing in Bioatla (BCAB) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Bioatla stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Bioatla share’s latest price of $0.45 as on August 30, 2025 at 1:29 am IST, you will get 22.2222 shares of Bioatla. Learn more about fractional shares .

What are the returns that Bioatla has given to Indian investors in the last 5 years?

Bioatla stock has given -98.54% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?